Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade.
about
Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges.Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs.Antitumor effects of baicalin on ovarian cancer cells through induction of cell apoptosis and inhibition of cell migration in vitro.
P2860
Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Bitter Melon (Momordica charan ...... geting AMPK Signaling Cascade.
@en
Bitter Melon
@nl
type
label
Bitter Melon (Momordica charan ...... geting AMPK Signaling Cascade.
@en
Bitter Melon
@nl
prefLabel
Bitter Melon (Momordica charan ...... geting AMPK Signaling Cascade.
@en
Bitter Melon
@nl
P2093
P2860
P50
P356
P1476
Bitter Melon (Momordica charan ...... rgeting AMPK Signaling Cascade
@en
P2093
D Grahame Hardie
Fiona A Ross
Jinbiao Zhan
Thomas H Y Leung
P2860
P304
P356
10.1177/1534735415611747
P577
2015-10-19T00:00:00Z